{"id":"https://openalex.org/W4407977346","doi":"https://doi.org/10.1016/j.jtct.2025.01.021","title":"NKTR-255 Vs Placebo to Enhance Complete Responses and Durability Following CD19-Directed CAR-T Therapy in Patients with Relapsed/ Refractory (R/R) Large B-Cell Lymphoma (LBCL)","display_name":"NKTR-255 Vs Placebo to Enhance Complete Responses and Durability Following CD19-Directed CAR-T Therapy in Patients with Relapsed/ Refractory (R/R) Large B-Cell Lymphoma (LBCL)","publication_year":2025,"publication_date":"2025-02-01","ids":{"openalex":"https://openalex.org/W4407977346","doi":"https://doi.org/10.1016/j.jtct.2025.01.021"},"language":"en","primary_location":{"id":"doi:10.1016/j.jtct.2025.01.021","doi":"https://doi.org/10.1016/j.jtct.2025.01.021","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2025.01.021","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.jtct.2025.01.021","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039574726","display_name":"Sairah Ahmed","orcid":"https://orcid.org/0000-0001-7302-8299","observed_orcids":["https://orcid.org/0000-0001-7302-8299"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sairah Ahmed","raw_affiliation_strings":["Department of Lymphoma/Myeloma and Stem Cell Transplant/Cellular Therapy, MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma/Myeloma and Stem Cell Transplant/Cellular Therapy, MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065066309","display_name":"John F. DiPersio","orcid":"https://orcid.org/0000-0002-0429-3133","observed_orcids":["https://orcid.org/0000-0002-0429-3133"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John F. DiPersio","raw_affiliation_strings":["Department of Medicine, Division of Oncology, Washington University in Saint Louis, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Oncology, Washington University in Saint Louis, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044422916","display_name":"James H. Essell","orcid":"https://orcid.org/0000-0002-9173-0310","observed_orcids":["https://orcid.org/0000-0002-9173-0310"]},"institutions":[{"id":"https://openalex.org/I4210153992","display_name":"Oncology Hematology Care","ror":"https://ror.org/04gqr8882","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210153992"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Essell","raw_affiliation_strings":["Oncology Hematology Care, OHC, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Hematology Care, OHC, Cincinnati, OH","institution_ids":["https://openalex.org/I4210153992"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014995908","display_name":"Catherine Diefenbach","orcid":"https://orcid.org/0000-0003-1116-3246","observed_orcids":["https://orcid.org/0000-0003-1116-3246"]},"institutions":[{"id":"https://openalex.org/I4390039310","display_name":"NYU Langone\u2019s Laura and Isaac Perlmutter Cancer Center","ror":"https://ror.org/00sa8g751","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Diefenbach","raw_affiliation_strings":["Perlmutter Cancer Center, NYU Grossman Medical School, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Perlmutter Cancer Center, NYU Grossman Medical School, New York, NY","institution_ids":["https://openalex.org/I4390039310","https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082333371","display_name":"Miguel\u2010Angel Perales","orcid":"https://orcid.org/0000-0002-5910-4571","observed_orcids":["https://orcid.org/0000-0002-5910-4571"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Miguel-Angel Perales","raw_affiliation_strings":["Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christina Castilla Llorente","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christina Castilla Llorente","raw_affiliation_strings":["Gustave Roussy Cancer Campus Grand Paris, Villejuif, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gustave Roussy Cancer Campus Grand Paris, Villejuif, Paris, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019559985","display_name":"Saurabh Dahiya","orcid":"https://orcid.org/0000-0001-8291-1796","observed_orcids":["https://orcid.org/0000-0001-8291-1796"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saurabh Dahiya","raw_affiliation_strings":["Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100409272","display_name":"Heng Xu","orcid":"https://orcid.org/0000-0001-8457-7613","observed_orcids":["https://orcid.org/0000-0001-8457-7613"]},"institutions":[{"id":"https://openalex.org/I2800689049","display_name":"Nektar Therapeutics (United States)","ror":"https://ror.org/03p1cbx82","country_code":"US","type":"company","lineage":["https://openalex.org/I2800689049"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heng Xu","raw_affiliation_strings":["Nektar Therapeutics, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nektar Therapeutics, San Francisco, CA","institution_ids":["https://openalex.org/I2800689049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089543099","display_name":"Christie P. Fanton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800689049","display_name":"Nektar Therapeutics (United States)","ror":"https://ror.org/03p1cbx82","country_code":"US","type":"company","lineage":["https://openalex.org/I2800689049"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christie Fanton","raw_affiliation_strings":["Nektar Therapeutics, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nektar Therapeutics, San Francisco, CA","institution_ids":["https://openalex.org/I2800689049"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sohail Chaudhry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800689049","display_name":"Nektar Therapeutics (United States)","ror":"https://ror.org/03p1cbx82","country_code":"US","type":"company","lineage":["https://openalex.org/I2800689049"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sohail Chaudhry","raw_affiliation_strings":["Nektar Therapeutics, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nektar Therapeutics, San Francisco, CA","institution_ids":["https://openalex.org/I2800689049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103176744","display_name":"Zachary Lee","orcid":"https://orcid.org/0009-0004-9516-9024","observed_orcids":["https://orcid.org/0009-0004-9516-9024"]},"institutions":[{"id":"https://openalex.org/I2800689049","display_name":"Nektar Therapeutics (United States)","ror":"https://ror.org/03p1cbx82","country_code":"US","type":"company","lineage":["https://openalex.org/I2800689049"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zachary Lee","raw_affiliation_strings":["Nektar Therapeutics, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nektar Therapeutics, San Francisco, CA","institution_ids":["https://openalex.org/I2800689049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059340436","display_name":"Mario Q. Marcondes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800689049","display_name":"Nektar Therapeutics (United States)","ror":"https://ror.org/03p1cbx82","country_code":"US","type":"company","lineage":["https://openalex.org/I2800689049"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mario Q. Marcondes","raw_affiliation_strings":["Nektar Therapeutics, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nektar Therapeutics, San Francisco, CA","institution_ids":["https://openalex.org/I2800689049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071236842","display_name":"Mary Ann Tagliaferri","orcid":"https://orcid.org/0000-0002-1043-2662","observed_orcids":["https://orcid.org/0000-0002-1043-2662"]},"institutions":[{"id":"https://openalex.org/I2800689049","display_name":"Nektar Therapeutics (United States)","ror":"https://ror.org/03p1cbx82","country_code":"US","type":"company","lineage":["https://openalex.org/I2800689049"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary A. Tagliaferri","raw_affiliation_strings":["Nektar Therapeutics, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nektar Therapeutics, San Francisco, CA","institution_ids":["https://openalex.org/I2800689049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011698346","display_name":"Jonathan Zalevsky","orcid":"https://orcid.org/0000-0003-2707-1709","observed_orcids":["https://orcid.org/0000-0003-2707-1709"]},"institutions":[{"id":"https://openalex.org/I2800689049","display_name":"Nektar Therapeutics (United States)","ror":"https://ror.org/03p1cbx82","country_code":"US","type":"company","lineage":["https://openalex.org/I2800689049"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Zalevsky","raw_affiliation_strings":["Nektar Therapeutics, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nektar Therapeutics, San Francisco, CA","institution_ids":["https://openalex.org/I2800689049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081926380","display_name":"David Bernard Miklos","orcid":"https://orcid.org/0000-0003-0717-4305","observed_orcids":["https://orcid.org/0000-0003-0717-4305"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David B. Miklos","raw_affiliation_strings":["Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089990813","display_name":"Cameron John Turtle","orcid":"https://orcid.org/0000-0002-4722-4461","observed_orcids":["https://orcid.org/0000-0002-4722-4461"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Cameron J. Turtle","raw_affiliation_strings":["University of Sydney School of Medicine, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Sydney School of Medicine, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052064208","display_name":"Joseph P. McGuirk","orcid":"https://orcid.org/0000-0002-0539-4796","observed_orcids":["https://orcid.org/0000-0002-0539-4796"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph P McGuirk","raw_affiliation_strings":["Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210128618"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5039574726"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":{"value":3650,"currency":"USD","value_usd":3650},"fwci":1.2443,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.78186123,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":97},"biblio":{"volume":"31","issue":"2","first_page":"S11","last_page":"S12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd19-car-t-cell-therapy","display_name":"CD19 CAR T-cell therapy","score":0.8209999799728394},{"id":"https://openalex.org/keywords/large-b-cell-lymphoma","display_name":"large B-cell lymphoma","score":0.9039999842643738},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.9890000224113464},{"id":"https://openalex.org/keywords/axicabtagene-ciloleucel","display_name":"axicabtagene ciloleucel","score":0.9599999785423279},{"id":"https://openalex.org/keywords/lisocabtagene-maraleucel","display_name":"lisocabtagene maraleucel","score":0.9890000224113464},{"id":"https://openalex.org/keywords/complete-response-rate","display_name":"complete response rate","score":0.7960000038146973},{"id":"https://openalex.org/keywords/car-t-cell-expansion","display_name":"CAR-T cell expansion","score":0.42500001192092896},{"id":"https://openalex.org/keywords/nk-cell-activation","display_name":"NK cell activation","score":0.45100000500679016},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.6050000190734863},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.5870000123977661},{"id":"https://openalex.org/keywords/sustained-remission","display_name":"sustained remission","score":0.4189999997615814},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.4320000112056732}],"concepts":[{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.7313790917396545},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6338995099067688},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6322176456451416},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5976358652114868},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49209874868392944},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4859582185745239},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08063024282455444},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.07475090026855469},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jtct.2025.01.021","doi":"https://doi.org/10.1016/j.jtct.2025.01.021","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2025.01.021","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jtct.2025.01.021","doi":"https://doi.org/10.1016/j.jtct.2025.01.021","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2025.01.021","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4413056100","https://openalex.org/W4310107863","https://openalex.org/W4310106082","https://openalex.org/W4400351981","https://openalex.org/W3212871396","https://openalex.org/W4411333768","https://openalex.org/W2983469478","https://openalex.org/W4308255853","https://openalex.org/W4388724826","https://openalex.org/W4417008360"],"abstract_inverted_index":{"CD19-directed":[0],"chimeric":[1],"antigen":[2],"receptor":[3],"(CAR)":[4],"have":[5,68],"high":[6],"response":[7,160],"rates":[8],"in":[9,76,107,297,311,322,381,401],"refractory":[10],"large":[11],"B-cell":[12],"lymphoma":[13],"(LBCL).":[14],"However,":[15],"more":[16],"than":[17],"half":[18],"of":[19,32,59,71,100,122,128,218,377,394],"patients":[20,79,137,199,210],"fail":[21],"to":[22,29,89,153,181,235,259,397,412,424],"achieve":[23],"remission":[24],"and/or":[25],"relapse.":[26],"Thus,":[27],"strategies":[28],"improve":[30],"efficacy":[31],"CAR-T":[33,72,83,87,110,131,149,193,282,425],"cell":[34,213,399,414],"products":[35,132],"are":[36,431],"needed.":[37],"NKTR-255":[38,67,106,123,190,237,280,321,350,367,395,422],"is":[39,114],"an":[40],"investigational":[41],"polymer-conjugated":[42],"IL-15":[43],"agonist":[44],"that":[45],"activates,":[46],"proliferates":[47],"and":[48,51,73,86,185,192,206,215,225,255,262,293,300,309,335,406,427],"expands":[49],"CD8+T":[50,74],"NK":[52],"cells,":[53],"as":[54,56],"well":[55],"promote":[57],"creation":[58],"memory":[60],"CD8+":[61],"T":[62],"cells.":[63,174],"Clinical":[64],"studies":[65,420],"with":[66,109,138,200,320,357,374,421],"shown":[69],"expansion":[70],"cells":[75,379],"R/R":[77,139],"NHL":[78],"who":[80,287],"previously":[81],"received":[82,141,211,223,228,288],"therapy":[84,111,214,400,415,426],"(NCT04136756),":[85],"trafficking":[88],"the":[90,236,344],"tumor":[91,270],"microenvironment":[92],"(Muffly,":[93],"2024;":[94],"NCT03233854).":[95],"Here,":[96],"we":[97],"describe":[98],"results":[99],"a":[101,115],"Phase":[102],"2":[103,117,278],"trial":[104],"evaluating":[105],"combination":[108],"(NCT05664217).":[112],"This":[113],"phase":[116],"randomized,":[118],"double-blind,":[119],"placebo-controlled":[120],"study":[121,142,219],"vs":[124,275,354,371],"placebo":[125],"following":[126,148,281],"one":[127],"two":[129],"FDA-approved":[130],"(axicabtagene-ciloleucel":[133],"or":[134],"lisocabtagene-maraleucel).":[135],"Eligible":[136],"LBCL":[140,201,402],"drug":[143],"intravenously":[144],"starting":[145],"+14":[146],"days":[147],"infusion":[150],"for":[151,349,366,384],"up":[152],"5":[154],"months.":[155],"Primary":[156],"endpoint":[157],"was":[158,176,283,325,351,368,403],"complete":[159],"rate":[161,410],"(CRR)":[162],"by":[163,178,196],"blinded":[164],"independent":[165],"central":[166],"review":[167],"(BICR)":[168],"at":[169,239,243,247,346,363,417],"month":[170,347,364],"6":[171,251,348,365],"after":[172],"CD19-CAR-T":[173,212,398,413],"Efficacy":[175],"assessed":[177],"PET-CT":[179],"according":[180],"Lugano.":[182],"Key":[183],"secondary":[184],"exploratory":[186],"objectives":[187],"included":[188],"safety/tolerability,":[189],"PK":[191],"PD":[194,387],"quantified":[195],"flow-cytometry.":[197],"15":[198],"were":[202,233,257,264,295,306],"randomized":[203,234,258],"between":[204,266],"Mar":[205],"Dec":[207],"2023.":[208],"All":[209],"\u22651":[216],"dose":[217],"treatment;":[220],"12/15":[221],"(80%)":[222,370],"axi-cel":[224],"3/15":[226],"(20%)":[227],"liso-cel.":[229],"In":[230],"total,":[231],"11":[232,286],"(5":[238],"1.5":[240],"\u00b5g/kg;":[241,245],"3":[242,244,246,248],"\u00b5g/kg":[249,252],"then":[250],"cycle":[253],"2+)":[254],"4":[256],"placebo.":[260,358,375],"LDH":[261],"histology":[263],"similar":[265],"both":[267],"groups,":[268],"except":[269],"burden":[271],"(NKTR-255":[272],"median":[273],"1408":[274],"940":[276],"mm":[277],"placebo).":[279],"well-tolerated.":[284],"Among":[285],"NKTR-255,":[289],"infusion-related":[290],"reaction":[291],"(IRR)":[292],"fever":[294],"reported":[296],"2/11":[298,333,338],"(18%)":[299],"3/11":[301],"(27%)":[302],"pts,":[303],"respectively;":[304],"all":[305,340],"grade":[307,317],"1/2":[308],"resolved":[310],"24":[312],"hrs.":[313],"The":[314],"most":[315],"common":[316],"\u22653":[318],"TRAEs":[319],">1":[323],"patient":[324],"decreased":[326],"neutrophil":[327],"count":[328,332,337],"5/11":[329],"(46%),":[330],"platelet":[331],"(18%),":[334],"lymphocyte":[336],"(18%);":[339],"resolved.":[341],"Per":[342,359],"intent-to-treat,":[343],"CRR":[345,362],"8/11":[352,382],"(73%)":[353,383],"2/4":[355,372],"(50%)":[356,373],"response-evaluable":[360],"analysis,":[361],"8/10":[369],"Re-expansion":[376],"CD8+CAR-T":[378],"occurred":[380],"NKTR-255.":[385],"Additional":[386],"analyses":[388],"will":[389],"be":[390],"presented.":[391],"Preliminary":[392],"data":[393],"adjuvant":[396,423],"well-tolerated,":[404],"safe":[405],"demonstrated":[407],"superior":[408],"CR":[409],"compared":[411],"alone":[416],"6-months.":[418],"Confirmatory":[419],"other":[428],"cellular":[429],"therapies":[430],"warranted.":[432]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2025-02-27T00:00:00"}